Skip to main content

Dermatitis Herpetiformis

  • Chapter
  • First Online:
Book cover Autoimmune Bullous Diseases

Abstract

Dermatitis herpetiformis (DH) is the specific skin manifestation of celiac disease (CD) caused by the digestion of gluten in HLA-DQ2 or HLA-DQ8 individuals. DH is characterized by intensely pruritic polymorphic papulovesicular eruption on the extensor surfaces of the body. Both diseases are characterized by circulating IgA autoantibodies against tissue transglutaminase (tTG), which bind to the smooth muscle layer of the monkey esophagus causing the so-called EMA positivity. In addition, DH patients have another autoantibody population targeting the epidermal transglutaminase (eTG), the autoantigen of DH, which protein is highly homologous to tTG.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med. 2002;195:747–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation. J Am Acad Dermatol. 2011;64:1017–24.

    Article  PubMed  Google Scholar 

  3. Preisz K, Sardy M, Horvath A, Karpati S. Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2005;19:74–9.

    Article  CAS  PubMed  Google Scholar 

  4. Karpati S. Dermatitis herpetiformis: close to unravelling a disease. J Dermatol Sci. 2004;34:83–90.

    Article  CAS  PubMed  Google Scholar 

  5. Thuong-Nguyen V, Kadunce DP, Hendrix JD, Gammon WR, Zone JJ. Inhibition of neutrophil adherence to antibody by dapsone: a possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses. J Invest Dermatol. 1993;100:349–55.

    Article  CAS  PubMed  Google Scholar 

  6. Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol. 2001;45:420–34.

    Article  CAS  PubMed  Google Scholar 

  7. Kempeneers D, De Haes P. Dapsone, nog steeds nuttig in de dermatologie? (article in Dutch). Ned Tijdschr Dermatol Venereol. 2011;21:362–7.

    Google Scholar 

  8. Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med. 1999;34:646–56.

    Article  CAS  PubMed  Google Scholar 

  9. Sárdy M, Tietze J. Dermatitis herpetiformis. An update of the pathogenesis. Hautarzt. 2009;60:627–32.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Barbara Horváth MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Horváth, B., Jonkman, M.F. (2016). Dermatitis Herpetiformis. In: Jonkman, M. (eds) Autoimmune Bullous Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-23754-1_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-23754-1_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-23753-4

  • Online ISBN: 978-3-319-23754-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics